New Home at Alexandria LaunchLabs
We have officially moved from our founding location at BioLabs@NYU Langone to Alexandria LaunchLabs, a leading life sciences innovation space in New York City. This move marks another step forward in our mission to develop next-generation oncolytic viruses for cancer therapy.
Why This Move Matters
Relocating our lab, to us, is more than a logistical undertaking—it reflects the evolution of our platform and the increasing scale of our research. Over the past few years, BioLabs@NYU Langone provided an environment that allowed our early ideas to grow into data-driven breakthroughs. We’re grateful for the support, infrastructure, and community that helped shape the foundation of our work.
Our move to Alexandria LaunchLabs signals a new phase. Located within a dynamic ecosystem of emerging biotech companies and strategic partners, the space offers expanded lab infrastructure, shared resources, and proximity to potential collaborators. These upgrades will allow us to accelerate our development of precision virotherapies with a focus on safety, specificity, and manufacturability.
Behind the Scenes: How We Made the Move
Relocating a working biotech lab requires detailed planning and precise coordination. Over the course of three weeks, we prepared every aspect—from decontaminating equipment to updating inventories and organizing cold-chain logistics. The goal was clear: minimize downtime, preserve continuity, and restart experiments quickly.
On April 30, we completed the move in a single day. Despite the usual surprises that come with transporting a fully functional lab, we worked with focus and adaptability. Within the first week, our new space was operational—an outcome made possible by thoughtful planning and strong internal collaboration.
What This Means for Our Platform
As we shared before, our work is centered on engineering Vesicular Stomatitis Virus based therapies designed to selectively target and destroy cancer cells. The new lab environment strengthens our ability to iterate on these designs, validate experimental results, and refine manufacturing strategies. What is exciting is that the new location has its own vivarium, which gives us the possibility to host our own mouse studies. This can further accelerate our work and we are already evaluating how to fit this into our planning.
Looking Forward
In joining Alexandria LaunchLabs we are aligning our scientific goals with an ecosystem that fosters innovation, collaboration, and clinical readiness. We’re energized by the opportunities this transition brings—not only for our internal research but also for partnerships that will be key to bringing virotherapies to patients.
To everyone who has supported us on this journey—thank you. We’re excited about what’s ahead and look forward to sharing updates as we continue to build the future of cancer therapy.
— Rupsa